FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

41168611000001103: Nevirapine 400mg modified-release tablets (Milpharm Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Nov 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2510701000001118 Nevirapine 400mg modified-release tablets (Milpharm Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2510721000001113 Nevirapine 400mg modified-release tablets (Milpharm Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nevirapine 400mg modified-release tablets (Milpharm Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Milpharm Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Milpharm Ltd) Is a Product containing precisely nevirapine 400 milligram/1 each prolonged-release oral tablet true Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Milpharm Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Milpharm Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Milpharm Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Milpharm Ltd) Has specific active ingredient Nevirapine true Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Milpharm Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Milpharm Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nevirapine 400mg modified-release tablets (Milpharm Ltd) 30 tablet 3 x 10 tablets Has AMP True Nevirapine 400mg modified-release tablets (Milpharm Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start